Opiant Pharmaceuticals (OPNT) Tops Q3 EPS by 85c
Tweet
Share
E-mailGet Alerts OPNT Hot Sheet
Price: $20.65 --0%
Financial Fact:
Interest and other expense, net: 34K
Today's EPS Names:
ELWT, CAAP, RNW, More
Financial Fact:
Interest and other expense, net: 34K
Today's EPS Names:
ELWT, CAAP, RNW, More
Join SI Premium – FREE
Opiant Pharmaceuticals (NASDAQ: OPNT) reported Q3 EPS of $0.77, $0.85 better than the analyst estimate of ($0.08). Revenue for the quarter came in at $16.3 million versus the consensus estimate of $10.21 million.
For earnings history and earnings-related data on Opiant Pharmaceuticals (OPNT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla to launch Cybercab in Austin this month - report
- KeyBanc Downgrades Kite Realty Group (KRG) to Sector Weight
- BofA Securities Downgrades Autohome Inc. (ATHM) to Underperform
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
